{"id":19904,"date":"2024-10-02T11:32:15","date_gmt":"2024-10-02T11:32:15","guid":{"rendered":"https:\/\/www.ttci-th.org\/?p=19904"},"modified":"2024-12-01T11:37:21","modified_gmt":"2024-12-01T11:37:21","slug":"revcar-expressing-immune","status":"publish","type":"post","link":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/","title":{"rendered":"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma"},"content":{"rendered":"You must be logged in to view this content.","protected":false},"excerpt":{"rendered":"You must be logged in to view this content.","protected":false},"author":4,"featured_media":19906,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[182],"tags":[],"class_list":["post-19904","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-members"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.2 - aioseo.com -->\n\t<meta name=\"description\" content=\"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin@narisara\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.2\" \/>\n\t\t<meta property=\"og:locale\" content=\"th_TH\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) - TTCI-TH\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma\" \/>\n\t\t<meta property=\"og:description\" content=\"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/10\/11.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/10\/11.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2024-10-02T11:32:15+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2024-12-01T11:37:21+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/web.facebook.com\/ttci.th\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@ttci_th\" \/>\n\t\t<meta name=\"twitter:title\" content=\"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma\" \/>\n\t\t<meta name=\"twitter:description\" content=\"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@ttci_th\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2023\/05\/cropped-cropped-TTCI_LOGO__PNG_-001-removebg-preview.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/revcar-expressing-immune\\\/#blogposting\",\"name\":\"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma\",\"headline\":\"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma\",\"author\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/11.png\",\"width\":1080,\"height\":1080},\"datePublished\":\"2024-10-02T11:32:15+00:00\",\"dateModified\":\"2024-12-01T11:37:21+00:00\",\"inLanguage\":\"th\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/revcar-expressing-immune\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/revcar-expressing-immune\\\/#webpage\"},\"articleSection\":\"Member Content\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/revcar-expressing-immune\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/members\\\/#listItem\",\"name\":\"Member Content\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/members\\\/#listItem\",\"position\":2,\"name\":\"Member Content\",\"item\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/members\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/revcar-expressing-immune\\\/#listItem\",\"name\":\"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/revcar-expressing-immune\\\/#listItem\",\"position\":3,\"name\":\"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/members\\\/#listItem\",\"name\":\"Member Content\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#organization\",\"name\":\"Thailand Hub of Talents in Cancer Immunotherapy\",\"description\":\"TTCI-TH\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/cropped-cropped-TTCI_LOGO__PNG_-001-removebg-preview.png\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/revcar-expressing-immune\\\/#organizationLogo\",\"width\":512,\"height\":512},\"image\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/revcar-expressing-immune\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/web.facebook.com\\\/ttci.th\\\/\",\"https:\\\/\\\/www.twitter.com\\\/ttci_th\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/\",\"name\":\"admin@narisara\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/revcar-expressing-immune\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/75b4fa1780d4337192829073b76451e4e65b3d665abf974c24531ee7367104a4?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin@narisara\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/revcar-expressing-immune\\\/#webpage\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/revcar-expressing-immune\\\/\",\"name\":\"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma\",\"description\":\"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com\",\"inLanguage\":\"th\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/revcar-expressing-immune\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/11.png\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/revcar-expressing-immune\\\/#mainImage\",\"width\":1080,\"height\":1080},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/revcar-expressing-immune\\\/#mainImage\"},\"datePublished\":\"2024-10-02T11:32:15+00:00\",\"dateModified\":\"2024-12-01T11:37:21+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#website\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/\",\"name\":\"Thailand Hub of Talents in Cancer Immunotherapy\",\"description\":\"TTCI-TH\",\"inLanguage\":\"th\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma","description":"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com","canonical_url":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/#blogposting","name":"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma","headline":"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma","author":{"@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author"},"publisher":{"@id":"https:\/\/www.ttci-th.org\/th\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/10\/11.png","width":1080,"height":1080},"datePublished":"2024-10-02T11:32:15+00:00","dateModified":"2024-12-01T11:37:21+00:00","inLanguage":"th","mainEntityOfPage":{"@id":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/#webpage"},"isPartOf":{"@id":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/#webpage"},"articleSection":"Member Content"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/#listItem","position":1,"name":"Home","item":"https:\/\/www.ttci-th.org\/th\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/members\/#listItem","name":"Member Content"}},{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/members\/#listItem","position":2,"name":"Member Content","item":"https:\/\/www.ttci-th.org\/th\/category\/members\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/#listItem","name":"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/#listItem","position":3,"name":"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma","previousItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/members\/#listItem","name":"Member Content"}}]},{"@type":"Organization","@id":"https:\/\/www.ttci-th.org\/th\/#organization","name":"Thailand Hub of Talents in Cancer Immunotherapy","description":"TTCI-TH","url":"https:\/\/www.ttci-th.org\/th\/","logo":{"@type":"ImageObject","url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2023\/05\/cropped-cropped-TTCI_LOGO__PNG_-001-removebg-preview.png","@id":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/#organizationLogo","width":512,"height":512},"image":{"@id":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/#organizationLogo"},"sameAs":["https:\/\/web.facebook.com\/ttci.th\/","https:\/\/www.twitter.com\/ttci_th\/"]},{"@type":"Person","@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author","url":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/","name":"admin@narisara","image":{"@type":"ImageObject","@id":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/75b4fa1780d4337192829073b76451e4e65b3d665abf974c24531ee7367104a4?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin@narisara"}},{"@type":"WebPage","@id":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/#webpage","url":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/","name":"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma","description":"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com","inLanguage":"th","isPartOf":{"@id":"https:\/\/www.ttci-th.org\/th\/#website"},"breadcrumb":{"@id":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/#breadcrumblist"},"author":{"@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author"},"creator":{"@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/10\/11.png","@id":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/#mainImage","width":1080,"height":1080},"primaryImageOfPage":{"@id":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/#mainImage"},"datePublished":"2024-10-02T11:32:15+00:00","dateModified":"2024-12-01T11:37:21+00:00"},{"@type":"WebSite","@id":"https:\/\/www.ttci-th.org\/th\/#website","url":"https:\/\/www.ttci-th.org\/th\/","name":"Thailand Hub of Talents in Cancer Immunotherapy","description":"TTCI-TH","inLanguage":"th","publisher":{"@id":"https:\/\/www.ttci-th.org\/th\/#organization"}}]},"og:locale":"th_TH","og:site_name":"Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) - TTCI-TH","og:type":"article","og:title":"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma","og:description":"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com","og:url":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/","og:image":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/10\/11.png","og:image:secure_url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/10\/11.png","og:image:width":"1080","og:image:height":"1080","article:published_time":"2024-10-02T11:32:15+00:00","article:modified_time":"2024-12-01T11:37:21+00:00","article:publisher":"https:\/\/web.facebook.com\/ttci.th\/","twitter:card":"summary_large_image","twitter:site":"@ttci_th","twitter:title":"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma","twitter:description":"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com","twitter:creator":"@ttci_th","twitter:image":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2023\/05\/cropped-cropped-TTCI_LOGO__PNG_-001-removebg-preview.png"},"aioseo_meta_data":{"post_id":"19904","title":"#post_title","description":null,"keywords":[],"keyphrases":{"focus":{"keyphrase":"RevCAR-expressing immune ","score":58,"analysis":{"keyphraseInTitle":{"score":9,"maxScore":9,"error":0},"keyphraseInDescription":{"score":3,"maxScore":9,"error":1},"keyphraseLength":{"score":9,"maxScore":9,"error":0,"length":2},"keyphraseInURL":{"score":5,"maxScore":5,"error":0},"keyphraseInIntroduction":{"score":3,"maxScore":9,"error":1},"keyphraseInSubHeadings":[],"keyphraseInImageAlt":[],"keywordDensity":{"score":0,"type":"low","maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":"#post_title","og_description":null,"og_object_type":"default","og_image_type":"featured","og_image_url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/10\/11.png","og_image_width":"1080","og_image_height":"1080","og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"created":"2024-12-01 11:35:15","updated":"2026-09-03 07:04:11","focus_keyword":"RevCAR-expressing immune","additional_keywords":null,"truseo_locale":null,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.ttci-th.org\/th\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.ttci-th.org\/th\/category\/members\/\" title=\"Member Content\">Member Content<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tRevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.ttci-th.org\/th\/"},{"label":"Member Content","link":"https:\/\/www.ttci-th.org\/th\/category\/members\/"},{"label":"RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma","link":"https:\/\/www.ttci-th.org\/th\/revcar-expressing-immune\/"}],"_links":{"self":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/posts\/19904","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/comments?post=19904"}],"version-history":[{"count":0,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/posts\/19904\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/media\/19906"}],"wp:attachment":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/media?parent=19904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/categories?post=19904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/tags?post=19904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}